J Frontier Co.,Ltd. agreed to acquire Manufacture and sale of LILAY series products business from Lycka Inc.
December 28, 2021
Share
J Frontier Co.,Ltd. (TSE:2934) agreed to acquire Manufacture and sale of LILAY series products business from Lycka Inc. on December 28, 2021. Manufacture and sale of LILAY series products business reported sales of ¥102 million for the year ended January, 2021.
J Frontier Co Ltd is a Japan-based company mainly engaged in the electronic commerce sale business for healthcare-related products and pharmaceuticals, the provision of online medication guidance, drug delivery platform SOKUYAKU, as well as the Internet advertising agency business for healthcare-related services. The Company operates through three business segments. The Healthcare Sales segment is engaged in the planning and development of health foods and cosmetics represented by the 328 selection series of fermented hydrogen and mail-order sales. The Medical Care Sales segment is engaged in the operation of dispensing pharmacies, mail-order business of ethical drugs, as well as planning, development and mail-order sales of drugs such as Why Pure series and Chinese herbs. The Health Care Marketing segment is mainly engaged in advertising agency business related to health care products, sales promotion support for health care products, as well as wholesale of in-house products.
J FRONTIER CO.,LTD. 
